Retrospective Data Analysis of CKRT (Continuous Kidney Replacement Therapy) Treatments in Adult Mode With multiFiltratePRO

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-05-01

Study Completion Date

2025-02-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The multiFiltratePRO is a device for extracorporeal blood purification treatments.

In this retrospective analysis, the treatments of patients who received at least one treatment with the investigational device as mentioned between January 2015 and January 2024 will be documented in a chronological order. No further control treatments will be investigated in this one-arm design. The design is considered to be appropriate to reflect daily clinical practice and to contribute to empirical evidence of performance of the multiFiltratePRO system.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Mesenchymal Stem Cells and Subclinical Rejection

NCT00734396

Organ Transplantation

COMPLETED PHASE1/PHASE2

The smartNTx Trial: A Prospective, Randomized Controlled Trial (RCT) to Investigate Additional Interventional Telemedical Management Versus Standard Aftercare in Kidney Transplant Recipients (KTR)

NCT05897047

Kidney Transplant Rejection Kidney Transplant Failure

ACTIVE_NOT_RECRUITING NA

Renal Transporters After Renal Transplantation

NCT00427024

Kidney Transplantation Host vs Graft Reaction

UNKNOWN

Study Investigating Whether Robot-assisted Surgery Can Reduce Surgical Complications Following Kidney Transplantation

NCT05730257

End Stage Renal Disease Kidney Transplant; Complications

ACTIVE_NOT_RECRUITING NA

PROlonged Ex-vivo Normothermic Machine PERfusion for Kidney Regeneration

NCT04693325

End Stage Renal Disease

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Kidney Injury Renal Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

AKI patients

Patients with an indication for the extracorporeal blood treatment suffering from AKI who received CKRT adult mode treatment

multiFiltratePRO with all CKRT treatment modes

Intervention Type OTHER

Retrospective Data Analysis of CKRT treatments in adult mode with multiFiltratePRO

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

multiFiltratePRO with all CKRT treatment modes

Retrospective Data Analysis of CKRT treatments in adult mode with multiFiltratePRO

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients with an indication for the extracorporeal blood treatment suffering from AKI who received CKRT adult mode treatment for at least once with: Heparin-Continuous veno-venous hemofiltration Hep-CVVH (Pre CVVH, Post CVVH and Pre-Post CVVH), Heparin-Continuous veno-venous hemodialysis Hep-CVVHD, Heparin-Continuous veno-venous hemodiafiltration Hep-CVVHDF (Pre-CVVHDF and Post-CVVHDF), Citrate-Calcium(Ci-Ca)-CVVHD, Citrate-Calcium(Ci-Ca) CVVHDF, between January 2015 and January 2024, with the investigational device, have to be included in the study in chronological order.
* No age restriction for heparin modes
* Age ≥ 18 years for Ci-Ca modes at treatment start
* Patient´s body weight ≥ 40kg irrespective of age
* Acute Kidney Injury (AKI) OR chronic dialysis patients with clinical indication for CKRT

Exclusion Criteria

* Participation in an interventional clinical study during the retrospectively collected CKRT treatment data
* Previous participation in the same study

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No